Status
Conditions
About
Patients with a higher breast cancer risk (higher than 17% according to the IBIS calculation) will receive a 2D digital mammography together with a 3D tomosynthesis (so called combo tomo) of both breasts in two views in order to investigate the additional value of tomosynthesis in the diagnosis of breast cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,000 participants in 1 patient group
Loading...
Central trial contact
Hilde Vandenhoutte; Chantal Van Ongeval, MD, Phd
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal